Established 1921 in Switzerland, Sintetica is a pharmaceutical company delivering injectable anaesthetics and analgesics to patients worldwide, through innovative science and excellence in development, production and marketing.
With employees from over 30 different countries, Sintetica offers a global culture for a global market. Important ongoing projects in various stages of development are in the R&D pipeline to launch new products for new markets.
Sintetica Lines of Business (LOB). Sintetica has a portfolio of high quality products developed in Switzerland for anaesthesia, analgesia, hypotension and neuromodulation. Enhanced ready to use drug formulations assuring the fitting to the current standard of care. Modern short and medium acting local anesthetics to adapt the length and conditions of anaesthesia allowing patients same day safe discharge. Analgesic, anesthetics and Neuromodulators for IT administration.
Sintetica site locations:
Headquarters and Sintetica Factory 1: Sintetica SA Via Penate 5, 6850 Mendrisio, Switzerland
Sintetica Factory 2: Sintetica SA Rue des Iles 4, 2108 Couvet, Switzerland
Sintetica GmbH: Albersloher Weg 11, 48155 Münster, Germany
Sintetica Limited: 30th Floor, 40 Bank Street, Canary Wharf, London E14 5NR, United Kingrom
Via Penate 5
|T.: +41 91 640 42 50|
|F.: +41 91 646 85 61|
Main activities Licensing-In ● Licensing-Out ● Co-development ●
Drug stages Pre-clinical ● Phase I - Phase III ● Registration ● Market ● Generic Plus (505B2) ● Generic ● Life cycle management ●
Therapeutic areas Cardiology ● Cardiovascular ● Local Anesthesia ● Ophtalmology ● Orthopedics ● Pain ●
Markets CH ● EU Top 5 ● Rest of Europe ● USA and Canada ● LATAM ● MENA ● BRICS ● ASEAN ● Africa ● Australia ● Brazil ● Korea ●
Drug product forms Injectable ● Spray ● Topical ○
Other activities (non pharma) Medical Devices ●